Cargando…

Endomyocardial fibrosis in Sudan: clinical and echocardiographic features

OBJECTIVE: Endomyocardial fibrosis (EMF) is a rare disease and is often an underdiagnosed and forgotten cardiomyopathy. The objective of this study was to document the current frequency of EMF in Sudan by defining and selecting cases from patients attending the echocardiography laboratory. Additiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalil, Siddiq Ibrahim, Khalil, Suha, El Tigani, Salma, Saad, Hanan A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642024/
https://www.ncbi.nlm.nih.gov/pubmed/28906536
http://dx.doi.org/10.5830/CVJA-2016-079
_version_ 1783271301862916096
author Khalil, Siddiq Ibrahim
Khalil, Suha
El Tigani, Salma
Saad, Hanan A
author_facet Khalil, Siddiq Ibrahim
Khalil, Suha
El Tigani, Salma
Saad, Hanan A
author_sort Khalil, Siddiq Ibrahim
collection PubMed
description OBJECTIVE: Endomyocardial fibrosis (EMF) is a rare disease and is often an underdiagnosed and forgotten cardiomyopathy. The objective of this study was to document the current frequency of EMF in Sudan by defining and selecting cases from patients attending the echocardiography laboratory. Additionally we aimed to create an EMF registry for Sudan. METHODS: The study started in January 2007 and is on-going. All the patients attending our echocardiography clinics in four different hospitals in Khartoum, Sudan, were included. Transthoracic echocardiography was used as the main diagnostic and selection tool. The diagnosis of EMF was based on predefined criteria and definitions, and was further supported by additional clinical, ECG, laboratory and chest X-ray findings. RESULTS: Out of 4 332 cases studied, 23 (0.5%) were found to have features of EMF. Females constituted 52% and the age range was 24 to 67 years. All patients presented with dyspnoea grades III–IV. Advanced heart failure with gross fluid overload was seen in 54% of cases and ascites was seen in 30%. EMF was biventricular in 53%, left ventricular in 29% and right ventricular in 18% of cases. Apical and ventricular wall fibrosis was found in all cases, followed by atrial enlargement, atrioventricular valve incompetence, ventricular cavity obliteration, restrictive flow pattern and pericardial effusion. Additional echocardiographic features are defined and discussed. CONCLUSION: Although a rare disease, cases of EMF can be identified in Sudan if a high index of suspicion is observed. New echocardiographic features of ventricular wall layering, endocardial fibrous shelf and endomyocardiopericarial fibrosis were identified and are discussed.
format Online
Article
Text
id pubmed-5642024
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Clinics Cardive Publishing
record_format MEDLINE/PubMed
spelling pubmed-56420242017-10-27 Endomyocardial fibrosis in Sudan: clinical and echocardiographic features Khalil, Siddiq Ibrahim Khalil, Suha El Tigani, Salma Saad, Hanan A Cardiovasc J Afr Cardiovascular Topics OBJECTIVE: Endomyocardial fibrosis (EMF) is a rare disease and is often an underdiagnosed and forgotten cardiomyopathy. The objective of this study was to document the current frequency of EMF in Sudan by defining and selecting cases from patients attending the echocardiography laboratory. Additionally we aimed to create an EMF registry for Sudan. METHODS: The study started in January 2007 and is on-going. All the patients attending our echocardiography clinics in four different hospitals in Khartoum, Sudan, were included. Transthoracic echocardiography was used as the main diagnostic and selection tool. The diagnosis of EMF was based on predefined criteria and definitions, and was further supported by additional clinical, ECG, laboratory and chest X-ray findings. RESULTS: Out of 4 332 cases studied, 23 (0.5%) were found to have features of EMF. Females constituted 52% and the age range was 24 to 67 years. All patients presented with dyspnoea grades III–IV. Advanced heart failure with gross fluid overload was seen in 54% of cases and ascites was seen in 30%. EMF was biventricular in 53%, left ventricular in 29% and right ventricular in 18% of cases. Apical and ventricular wall fibrosis was found in all cases, followed by atrial enlargement, atrioventricular valve incompetence, ventricular cavity obliteration, restrictive flow pattern and pericardial effusion. Additional echocardiographic features are defined and discussed. CONCLUSION: Although a rare disease, cases of EMF can be identified in Sudan if a high index of suspicion is observed. New echocardiographic features of ventricular wall layering, endocardial fibrous shelf and endomyocardiopericarial fibrosis were identified and are discussed. Clinics Cardive Publishing 2017 /pmc/articles/PMC5642024/ /pubmed/28906536 http://dx.doi.org/10.5830/CVJA-2016-079 Text en Copyright © 2015 Clinics Cardive Publishing http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiovascular Topics
Khalil, Siddiq Ibrahim
Khalil, Suha
El Tigani, Salma
Saad, Hanan A
Endomyocardial fibrosis in Sudan: clinical and echocardiographic features
title Endomyocardial fibrosis in Sudan: clinical and echocardiographic features
title_full Endomyocardial fibrosis in Sudan: clinical and echocardiographic features
title_fullStr Endomyocardial fibrosis in Sudan: clinical and echocardiographic features
title_full_unstemmed Endomyocardial fibrosis in Sudan: clinical and echocardiographic features
title_short Endomyocardial fibrosis in Sudan: clinical and echocardiographic features
title_sort endomyocardial fibrosis in sudan: clinical and echocardiographic features
topic Cardiovascular Topics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642024/
https://www.ncbi.nlm.nih.gov/pubmed/28906536
http://dx.doi.org/10.5830/CVJA-2016-079
work_keys_str_mv AT khalilsiddiqibrahim endomyocardialfibrosisinsudanclinicalandechocardiographicfeatures
AT khalilsuha endomyocardialfibrosisinsudanclinicalandechocardiographicfeatures
AT eltiganisalma endomyocardialfibrosisinsudanclinicalandechocardiographicfeatures
AT saadhanana endomyocardialfibrosisinsudanclinicalandechocardiographicfeatures